- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2020
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/12091
Title: | Pulmonary alveolar proteinosis: from house painting to diffuse lung disease |
Authors: | Chirita, George-Alexandru |
Keywords: | pulmonary alveolar proteinosis;diffuse lung disease;PAS positive;toxic exposure |
Issue Date: | 2020 |
Publisher: | MedEspera |
Citation: | CHIRITA, George-Alexandru. Pulmonary alveolar proteinosis: from house painting to diffuse lung disease. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 44. |
Abstract: | Background. Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the
accumulation of periodic acid-Schiff (PAS)-positive lipoproteinaceous material within the
alveoli resulting in hypoxemic respiratory failure. Secondary PAP due to heavy inhalation
exposure to inorganic dusts causes a reduction in the number and clearance capacity of alveolar
macrophages.
Case report. We present you the case of a 42-year-old Sudanese patient with a 17-pack years
smoking history who shows up at the hospital in December 2019 for dry cough, weight loss
and exertional dyspnea. The onset of the symptoms started 2 months earlier, after using
sandpaper on the walls while refurbishing his house. The initial diagnosis based on the clinical
context and chest X-ray was pulmonary tuberculosis. However, the Acid-Fast Bacillus (AFB)
smear was negative and the High-resolution CT showed a “crazy-paving” pattern. The blood
count showed no evidence of hematologic malignancy or myelodysplastic syndrome. A
flexible bronchoscopy to obtain bronchoalveolar lavage (BAL) fluid was performed. The
examination of the BAL fluid showed the presence of PAS-positive material and the growth of
E.coli colonies with no atypical cells found. Pulmonary function tests demonstrated a moderate
reduction in the diffusing capacity for carbon monoxide (DLCO). : Using all of the findings,
the diagnosis of secondary pulmonary alveolar proteinosis was established. The patient
received antibiotic treatment with ceftriaxone and ciprofloxacin. Whole lung lavage under
general anesthesia via a double-lumen endotracheal tube was performed, which proved to be
effective. The patient was advised to stop smoking and a regular check twice a year was
recommended.
Conclusions. Secondary PAP represents less than 10% of the total cases of pulmonary
proteinosis. Further tests should be performed to identify the exact etiology in this situation
The particularity of the case comes from the short exposure to the toxic, as well as its ethnic
background. |
URI: | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf http://repository.usmf.md/handle/20.500.12710/12091 |
Appears in Collections: | MedEspera 2020
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|